Lindbrook Capital, LLC Curis Inc Transaction History

Lindbrook Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$4.45 - $8.09 $35,600 - $64,720	-8,000 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$6.94 - $8.85 $6,856 - $8,743	988 Added 14.09%	8,000 $63,000
Q2 2021 Jul 27, 2021	BUY	$7.45 - $16.27 $27,810 - $60,735	3,733 Added 113.85%	7,012 $57,000
Q1 2021 Apr 28, 2021	SELL	$8.78 - $12.8 $32,670 - $47,628	-3,721 Reduced 53.16%	3,279 $37,000
Q4 2020 Jan 27, 2021	BUY	$1.08 - $8.2 $7,560 - $57,399	7,000 New	7,000 $57,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.